Patent · US Active

Tumor-infiltrating lymphocytes for adoptive cell therapy

US11518980B2 · kind B2 · utility

0Cited by

10References

22Claims

0Family size

Assignees

H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. · US
University of South Florida · US

Inventors

Amod A. Sarnaik · Tampa, US
Shari Pilon-Thomas · Tampa, US
Mark McLaughlin · Tampa, US
Hao Liu · Tampa, US

Key dates

Filing date	Feb 11, 2019
Grant date	Dec 6, 2022
Priority date	—
Expiry date	Jul 12, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/999
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compositions and methods for ex vivo expansion of tumor-infiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumor-infiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.